Reporting from the frontiers of health and medicine

Fusion CX takes full control of VA Platinum Offshoring in strategic acquisition

Fusion CX takes full control of VA Platinum Offshoring in strategic acquisition GenoMethods.org © genomethods.org
Fusion CX takes full control of VA Platinum Offshoring in strategic acquisition © genomethods.org
Fusion CX has bought all shares of VA Platinum Offshoring, with S&T; Legal guiding the deal from legal checks to closing.

Fusion CX now owns all of VA Platinum Offshoring. The deal, made through Fusion CX’s UK arm Fusion BPO Services Ltd., gives the company full control of an Australian staffing provider with subsidiaries in the Philippines.

S&T; Legal led the legal side. Partners Akshay Gosavi and Vidhan Gupta headed the team, with Ankit Pitti as Associate Partner and support from Associates Anusha Burman and Rajan Maheshwari. They handled every step: legal due diligence, structuring the deal, drafting and negotiating the Share Purchase Agreement, managing extra documents, and making sure all conditions were met before closing.

Fusion CX is recognized as a global BPO company with more than 10,000 employees and a headquarters in Pasig, Philippines, highlighting its extensive international operations.

The Manifest

This move is a clear expansion for Fusion CX. The company can now use VA Platinum Offshoring’s strong base in Australia and the Philippines. The legal team stayed involved from the first review to the final signatures, making sure the process followed strict standards and protected Fusion CX’s interests throughout.

This deal shows how important strong legal work and careful management are in offshore staffing and managed workforce deals. S&T; Legal’s team set a high bar for future cross-border acquisitions in this field.

By buying all of VA Platinum Offshoring’s shares, Fusion CX has made its intentions clear. The company relied on a legal team with real cross-border experience. This not only grew its reach but also showed its focus on careful, risk-aware growth. The deal is a model for how to handle strategic acquisitions in a tough market.

In a September 2026 interview, Fusion CX CEO Pankaj Dhanuka revealed that the company had earmarked approximately 80–85 crore rupees for further investments as part of its IPO strategy, reflecting a proactive approach to expansion and capital allocation.

SmallCapSpotlightInterview Publication

A September 2026 report by The Times of India says Fusion CX is also planning two more international acquisitions—one in Germany and one in the United States. This shows the VA Platinum deal is part of a bigger M&A plan. Fusion CX is pushing to grow its global reach through targeted cross-border deals.

So far, there is no independent confirmation of the financial terms, purchase price, percentage stake, or regulatory approvals in public sources. This lack of detail is common in private M&A deals, especially in the BPO and offshore staffing sector.

Vivian Lin Biotech markets and transactions editor GenoMethods.org
Biotechnology Newsroom

Vivian Lin

Vivian Lin is Biotech Markets & Transactions Editor at GenoMethods, covering licensing agreements, M&A, biotech financing, company pipelines, strategic partnerships and cross-border transactions. Her reporting connects deal structure and company strategy with the scientific and clinical evidence underlying each biotechnology asset.